摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-{3-[(4-Ethoxyphenyl)amino]-2-hydroxypropyl}-3-methyl-1-oxo-1,5-dihydropyrido[1,2-a]benzimidazole-4-carbonitrile

中文名称
——
中文别名
——
英文名称
5-{3-[(4-Ethoxyphenyl)amino]-2-hydroxypropyl}-3-methyl-1-oxo-1,5-dihydropyrido[1,2-a]benzimidazole-4-carbonitrile
英文别名
5-[3-(4-ethoxyanilino)-2-hydroxypropyl]-3-methyl-1-oxopyrido[1,2-a]benzimidazole-4-carbonitrile
5-{3-[(4-Ethoxyphenyl)amino]-2-hydroxypropyl}-3-methyl-1-oxo-1,5-dihydropyrido[1,2-a]benzimidazole-4-carbonitrile化学式
CAS
——
化学式
C24H24N4O3
mdl
——
分子量
416.5
InChiKey
CDKJKYXMDMEIDH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    31
  • 可旋转键数:
    7
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    88.8
  • 氢给体数:
    2
  • 氢受体数:
    6

文献信息

  • Small Molecule Inhibitors of Retroviral Assembly & Maturation
    申请人:New York Blood Center
    公开号:EP2335779A1
    公开(公告)日:2011-06-22
    Chemical compounds that disrupt retroviral assembly and maturation are presented herein. More particularly, this disclosure provides small molecule compounds that disrupt the formation and maturation of virus particles and methods of using such small molecules to treat HIV-1 infection.
    本文介绍了能破坏逆转录病毒组装和成熟的化学化合物。更具体地说,本公开提供了能破坏病毒颗粒的形成和成熟的小分子化合物,以及用这种小分子化合物治疗 HIV-1 感染的方法。
  • Small Molecule Inhibitors of Retroviral Assembly and Maturation
    申请人:Debnath Asim Kumar
    公开号:US20100035912A1
    公开(公告)日:2010-02-11
    Chemical compounds that disrupt retroviral assembly and maturation are presented herein. More particularly, this disclosure provides small molecule compounds that disrupt the formation and maturation of virus particles and methods of using such small molecules to treat HIV-1 infection.
  • COMPOUNDS FOR TREATING DISEASE, FOR ADMINISTERING, AND FOR PHARMACEUTICAL COMPOSITIONS
    申请人:Trent John O.
    公开号:US20130059852A1
    公开(公告)日:2013-03-07
    Some embodiments of this invention include methods for treating disease and methods for administering a compound of Formula (I). In some aspects of the invention, diseases can be treated by administration of compositions comprising a compound of Formula (I). Pharmaceutical compositions of some embodiments of the present invention comprise a compound of Formula (I).
  • US8299093B2
    申请人:——
    公开号:US8299093B2
    公开(公告)日:2012-10-30
  • US8546439B2
    申请人:——
    公开号:US8546439B2
    公开(公告)日:2013-10-01
查看更多